Begin main content

Reports

We found 4941 result(s)

fluocinolone acetate (Iluvien)

Last Updated: January 15, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: fluocinolone acetonide
Indications: Diabetic macular edema (DME)

  • Brand Name: Iluvien
  • Manufacturer: Knight Therapeutics Inc.
  • Project Number: SR0549-000
  • Project Status: Active
  • Submission Type: New

Tags

Eye, Diabetes

Dolutegravir / rilpivirine (TBC)

Last Updated: January 15, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: Dolutegravir rilpivirine
Indications: HIV infection

  • Brand Name: TBC
  • Manufacturer: ViiV Healthcare ULC
  • Project Number: SR0551-000
  • Project Status: Active
  • Submission Type: NewCombination

Tags

Infectious Diseases, HIV/AIDS, Infectious diseases

buprenorphine hydrochloride (Probuphine)

Last Updated: January 15, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: buprenorphine hydrochloride
Indications: Opioid drug dependence, treatment

  • Brand Name: Probuphine
  • Manufacturer: Knight Therapeutics Inc.
  • Project Number: SR0550-000
  • Project Status: Active
  • Submission Type: New

Tags

Mental Health, Addiction, Mental health

Per Oral Endoscopic Myotomy for Esophageal Motility Disorders: A Review of Clinical, Cost-Effectiveness, and Guidelines

Published on: January 15, 2018
Result type: Reports
Product Line: Rapid Response
Research Type: Devices and Systems

  • Project Number: RC0954-000

Tags

Endoscopy, Digestive System, Esophageal Motility Disorders, Esophageal Sphincter, Lower, Natural Orifice Endoscopic Surgery, Ear, nose, and throat, Surgery, peroral endoscopic myotomy (POEM), achalasia, endoscopic therapy, esophageal spasm

Levodopa / carbidopa (Drug Plan Submission) (Duodopa )

Last Updated: January 11, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: Levodopa / carbidopa (Drug Plan Submission)
Indications: Parkinson's disease

  • Brand Name: Duodopa
  • Manufacturer: AbbVie Corporation
  • Project Number: SR0557-000
  • Project Status: Pending
  • Submission Type: Resubmission

New at CADTH — January 2018

Published on: January 11, 2018
Result type: Reports
Product Line: New at CADTH

DRUG REIMBURSEMENT RECOMMENDATIONS CADTH Common Drug Review Read the following CDR Update to find out what’s happening in CDR: Issue 132 — Update on Revised Process for Biosimilars, and Clarification Regarding Eligibility Assessments for Resubmissions. Nusinersen (Spinraza): Spinal Muscular Atrophy CADTH pan-Canadian Oncology Drug Review (pCODR)...

nusinersen (Spinraza)

Last Updated: January 10, 2018
Result type: Reports
Product Line: Common Drug Review
Generic Name: nusinersen
Indications: Spinal Muscular Atrophy

  • Brand Name: Spinraza
  • Manufacturer: Biogen Canada Inc.
  • Project Number: SR0525-000
  • Project Status: Active
  • Submission Type: New

Tags

Muscular Atrophy, Spinal, Spinal Muscular Atrophies of Childhood, Parkinson, Spinraza; nusinersen; spinal muscular atrophy; spinal amyotrophy